MAYBELLE MADLOCK: Open Payments
NPI 1740250463 · RALEIGH, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,937 in 105 payments from 16 companies in 2025. Trend: 2023 $1,176 · 2024 $1,061 · 2025 $2,937
Food & beverage: $2,937
| Company | Payments | Amount |
|---|---|---|
| Galderma Laboratories, L.P. | 13 | $455 |
| ABBVIE INC. | 17 | $420 |
| Novartis Pharmaceuticals Corporation | 10 | $419 |
| LEO Pharma Inc. | 6 | $224 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 11 | $200 |
| Amgen Inc. | 5 | $199 |
| Janssen Biotech, Inc. | 4 | $188 |
| Arcutis Biotherapeutics, Inc. | 8 | $182 |
| Lilly USA, LLC | 12 | $180 |
| UCB, Inc. | 6 | $138 |
Products named: NEMLUVIO, RINVOQ, TREMFYA, Zoryve, SKYRIZI, DUPIXENT, ANZUPGO, Bimzelx.
Industry payments across NC — which companies pay providers there.
